Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Sana Biotechnology, Inc. (SANA) had Weighted-Average Shares Outstanding (Diluted) of 260.49M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-42.15M |
|
-- |
|
-- |
|
$43.52M |
|
$-43.52M |
|
$1.36M |
|
$-42.15M |
|
$-42.15M |
|
$-42.15M |
|
$-42.15M |
|
$-42.15M |
|
$-42.15M |
|
$-43.52M |
|
$-40.32M |
|
260.49M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
260.49M |
$-0.16 |
|
$-0.16 |
|
| Balance Sheet Financials | |
$161.76M |
|
$29.93M |
|
$273.67M |
|
$435.43M |
|
$35.51M |
|
-- |
|
$204.61M |
|
$240.12M |
|
$195.31M |
|
$-4.51M |
|
$195.31M |
|
262.26M |
|
| Cash Flow Statement Financials | |
$-111.19M |
|
$-23.74M |
|
$111.08M |
|
$131.40M |
|
$107.55M |
|
$-23.85M |
|
$19.13M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.55 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-110.48M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-21.58% |
|
933.81% |
|
-9.68% |
|
-21.58% |
|
$0.74 |
|
$-0.42 |
|
$-0.43 |
|